Giants of Gene Therapy Podcast
Hear from cell & gene therapy luminaries

Apple Spotify

Subscribe to the Podcast

ASGCT’s first podcast, Giants of Gene Therapy, is available on the ASGCT Podcast Network.

Society President Hans-Peter Kiem, MD, PhD, regularly interviews luminaries in the worlds of cell and gene therapy.

You can subscribe to the channel wherever you listen to your podcasts (including Apple, Spotify, Overcast, Pocket Casts, and more).

Search “ASGCT” in your podcast app to subscribe to the ASGCT Podcast Network

Luigi Naldini, MD, PhD

Hear Luigi Naldini, MD, PhD, the pioneer of lentivirus gene therapy, discuss his intercontinental career and the future of gene editing and use of lentiviral vectors. ASGCT President Hans-Peter Kiem, MD, PhD, hosted the one-on-one conversation.

Terry Flotte, MD

Hear Terry Flotte, MD, the PI for the first human use of AAV vectors in gene therapy, discuss the past and possible future of gene therapy, plus his inspiration to be a physician, scientist, and medical school dean. He spoke with ASGCT President Hans-Peter Kiem, MD, PhD. 

Jennifer Doudna, PhD

Hear Jennifer Doudna, PhD, a Nobel prize laureate, share her personal journey to co-inventing CRISPR-Cas9 for gene editing and the promise of her discovery. She spoke with ASGCT President Hans-Peter Kiem, MD, PhD. 

Drew Weissman, MD, PhD

Hear Drew Weissman, MD, PhD, share his personal journey and ups and downs of pioneering mRNA vaccines for COVID, HIV, food allergies, and more, during his conversation with ASGCT President Hans-Peter Kiem, MD, PhD. 

Carl June, MD

Hear Carl June, MD—researcher instrumental in bringing CAR T cells to the clinic. Dr. June discusses his journey from medical research officer in the Navy to leader behind the first FDA-approved gene therapy.  

Kathy High, MD

Hear Kathy High, MD, a lead researcher behind the first FDA-approved gene therapy for a rare form of inherited vision loss. She shared her personal and scientific journey with ASGCT President Hans-Peter Kiem, MD, PhD.

2023

Policy Summit

Sept. 18-19 | Washington, DC

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.